TriLink, Astral Scientific Forge Distribution Deal | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – TriLink BioTechnologies today announced a distribution deal covering Australia with Astral Scientific for its nucleic acid products.

Products covered by the deal include more than 150 modified nucleotides, custom oligonucleotides, and CleanAmp Hot Start PCR products, San Diego-based TriLink said.

Financial terms of the deal were not disclosed.

Astral supplies core consumables to the clinical diagnostic, life science, and industrial markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.